German Telecom Services and Carriers Stock News

XTRA:DHL
XTRA:DHLLogistics

Assessing Deutsche Post (XTRA:DHL) Valuation As Healthcare Logistics Expansion Gains Pace

DHL Group’s decision to bring more of its healthcare air cargo operations in-house, including pharma routes between Brussels and Cincinnati, has put Deutsche Post (XTRA:DHL) in sharper focus for investors watching specialised logistics revenue plans. See our latest analysis for Deutsche Post. Healthcare logistics moves such as bringing pharma air cargo in-house sit alongside a 6.74% 1 month share price return and 9.87% 3 month share price return, while the 1 year total shareholder return of...
XTRA:FRE
XTRA:FREHealthcare

Fresenius 5008X Rollout Tests Profit Ambitions And Valuation Gap

Fresenius Medical Care has launched its largest ever US product rollout with the 5008X hemodiafiltration machine. The company is planning a broad transition of US patients to the new system, alongside a sharp improvement in profitability. Management is framing 2026 as a transition year, with ongoing investments and adjustments to industry changes. For investors following Fresenius SE KGaA (XTRA:FRE), the 5008X launch comes at a time when the stock trades around €51.1 and has delivered a...
XTRA:GFT
XTRA:GFTIT

Assessing GFT Technologies (XTRA:GFT) Valuation As AI And M&A Interest Attract Fresh Attention

GFT Technologies (XTRA:GFT) is back on investors’ radar as its role in AI, cloud migration, and core banking modernization draws fresh attention, alongside speculation about potential interest from larger consulting groups or private equity buyers. See our latest analysis for GFT Technologies. Despite the current interest around AI and potential corporate interest, the share price tells a more cautious story, with a 30 day share price return of a 33% decline and a 1 year total shareholder...
XTRA:ENR
XTRA:ENRElectrical

Siemens Energy Nickel Upcycling Deal Adds New Angle To Growth Story

Siemens Energy and 6K Additive have entered a long term supply agreement to upcycle spent nickel alloy powder into additive manufacturing feedstock. The deal focuses on repurposing nickel alloy waste from Siemens Energy into high quality material for industrial 3D printing. The partnership aims to improve material efficiency and support circular use of critical metals in energy and manufacturing applications. For investors watching XTRA:ENR, this agreement adds a fresh angle to the story...
XTRA:GXI
XTRA:GXILife Sciences

Assessing Gerresheimer (XTRA:GXI) After A Sharp Pre Market Drop Ahead Of Earnings

What triggered the sudden move in Gerresheimer (XTRA:GXI)? Gerresheimer (XTRA:GXI) drew attention after a pre market move of more than 70% on low trading volume, just days ahead of its scheduled earnings release on 26 February 2026. See our latest analysis for Gerresheimer. That sharp pre market swing sits against a weak backdrop, with a 30 day share price return of 31.6% decline and a 1 year total shareholder return of 77.3% decline, suggesting momentum has been fading and market risk...
XTRA:RWE
XTRA:RWERenewable Energy

How RWE’s Norfolk Vanguard West Turbine Deal and KKR Partnership Will Impact RWE (XTRA:RWE) Investors

RWE has recently placed a firm order with Vestas for 92 V236-15.0 MW turbines for the 1,380 MW Norfolk Vanguard West offshore wind project in the UK, following its successful award of a Contract for Difference in Allocation Round 7 and targeting final investment decision in summer 2026 with commissioning in 2029. This contract, alongside KKR acquiring a 50% stake in the Norfolk Vanguard projects, underscores how RWE is advancing capital-light partnerships to expand its offshore wind...
XTRA:HOT
XTRA:HOTConstruction

A Look At HOCHTIEF’s (XTRA:HOT) Valuation As Earnings Rise And The Dividend Jumps 26%

Why HOCHTIEF’s latest earnings and dividend move matter for shareholders HOCHTIEF (XTRA:HOT) has caught investor attention after reporting 2025 results with higher sales and net income, announcing a 26% dividend increase to €6.60 per share, and issuing upgraded operational net profit guidance for 2026. The company reported 2025 sales of €38,236.46m compared with €33,301.27m a year earlier, while net income reached €902.33m versus €775.63m. Basic earnings per share from continuing operations...
XTRA:EOAN
XTRA:EOANIntegrated Utilities

A Look At E.ON (XTRA:EOAN) Valuation After Higher Earnings And Expanded 2030 Investment Plan

E.ON (XTRA:EOAN) shares are in focus after the company reported higher earnings alongside a raised investment plan running through 2030, highlighting its continued push into European energy infrastructure projects. See our latest analysis for E.ON. The share price has moved to €18.74, with a 30-day share price return of 10.56% and a 90-day share price return of 20.71%. The 1-year total shareholder return of 61.14% and 5-year total shareholder return of 173.98% point to momentum that has built...
XTRA:MTX
XTRA:MTXAerospace & Defense

MTU Aero Engines Record Results Raise Dividend And Test Cash Priorities

MTU Aero Engines (XTRA:MTX) reported record results for 2025, according to its latest update. The company announced a substantial dividend increase for shareholders. Management issued an optimistic 2026 outlook, pointing to strong demand and progress in its GTF program. MTU also highlighted ongoing expansion in its maintenance capabilities as part of its growth plans. MTU Aero Engines, listed as XTRA:MTX, is a key supplier in civil aerospace with a focus on engine programs such as the GTF...
XTRA:BAS
XTRA:BASChemicals

Assessing BASF (XTRA:BAS) Valuation As Recent Returns Send Mixed Signals

Recent performance snapshot for BASF BASF (XTRA:BAS) has been flat over the past day, with a 3.5% decline over the past week, a 6% gain over the past month, and roughly 9.5% over the past 3 months. Over longer periods, the stock shows a 9.1% gain year to date and a 5.6% total return over the past year, alongside a 22.5% total return over 3 years and a 5% total return decline over 5 years. See our latest analysis for BASF. At a share price of €48.87, BASF has paired a 6% 30 day share price...
XTRA:AFX
XTRA:AFXMedical Equipment

Is Carl Zeiss Meditec (XTRA:AFX) Offering Opportunity After A 52% One Year Share Price Slump

If you are wondering whether Carl Zeiss Meditec is starting to look like value after a tough run, this article will walk you through what the current share price might be implying. The stock has faced heavy pressure, with returns of a 1.7% decline over 7 days, a 6.4% decline over 30 days, a 33.0% decline year to date and a 52.4% decline over 1 year, plus a 78.4% decline over 3 years and 77.8% over 5 years. Recent coverage has focused on the company as a key player in medical technology and...
XTRA:VOW3
XTRA:VOW3Auto

Volkswagen Design Shift Under Mindt Raises Questions On Valuation And Demand

Volkswagen (XTRA:VOW3) has appointed Andreas Mindt as the new Group Head of Design. Mindt succeeds Michael Mauer as part of a generational transition in the company’s top design leadership. The move signals a refreshed approach to design at group level across the Volkswagen brands. For an automaker of Volkswagen’s scale, design is not just about looks; it shapes brand identity, pricing power, and how models stand out in crowded segments. As XTRA:VOW3 continues to compete across combustion,...
XTRA:FME
XTRA:FMEHealthcare

Fresenius Medical Care (XTRA:FME) Margin Rebound Tests Bearish Earnings Narratives

Fresenius Medical Care (XTRA:FME) closed out FY 2025 with Q4 revenue of €5.1b and basic EPS of €1.14, as full year trailing twelve month figures showed total revenue of €19.6b and EPS of €3.36. Over the past year, the company has seen quarterly revenue move between about €4.8b and €5.1b, while basic EPS has ranged from €0.52 in Q1 2025 to €1.14 in Q4 2025. This has occurred alongside trailing twelve month net income of €978m, which sits against earlier figures such as €538m at the end of...
XTRA:SMHN
XTRA:SMHNSemiconductor

Has SUSS MicroTec's (XTRA:SMHN) Enlarged Credit Line Quietly Rewritten Its Risk-Reward Profile?

SUSS MicroTec SE recently concluded a new syndicated loan agreement worth €115 million with a five-year term and two optional one-year extensions, replacing its prior €56 million facility that was set to expire in October 2026. By more than doubling its syndicated loan capacity with a consortium of renowned European banks, the company has increased its financial flexibility for general corporate needs and refinancing. Next, we’ll examine how this expanded €115 million syndicated loan...
XTRA:P911
XTRA:P911Auto

Assessing Porsche (XTRA:P911) Valuation As Shares Trade Near €41 With Mixed Recent Returns

Stock context and recent performance snapshot Dr. Ing. h.c. F. Porsche (XTRA:P911) has stayed on investors’ radar after recent trading, with the share price closing at €41.55 and short term returns mixed across the past week and month. Over the past 3 months the stock shows a negative total return, and the 1 year and 3 year total return figures are also negative. This may prompt you to look more closely at how current pricing compares with the company’s earnings and balance sheet. See our...
XTRA:SHL
XTRA:SHLMedical Equipment

Is Siemens Healthineers (XTRA:SHL) Now Attractive After A 22% One Year Share Price Fall

If you are wondering whether Siemens Healthineers is attractively priced at its current level, this article walks through what the numbers suggest and how that might matter for your portfolio. The stock last closed at €41.55, with returns of 1.5% over 7 days, a 4.0% decline over 30 days, a 5.9% decline year to date and a 21.9% decline over 1 year. These moves may catch the eye of investors weighing potential upside against recent share price pressure. Recent news flow around Siemens...
XTRA:IFX
XTRA:IFXSemiconductor

Assessing Infineon Technologies (XTRA:IFX) Valuation After New €2.0b Bond Issuance

Infineon’s new bond issues and why they matter for equity investors Infineon Technologies (XTRA:IFX) has just raised fresh debt across three new euro bonds, a move that gives the semiconductor group extra flexibility around funding, refinancing, and future investment plans. The company completed fixed income offerings totaling about €2.0b on 12 February 2026, issuing unsubordinated unsecured notes with fixed coupons and staggered maturities in 2031, 2034, and 2037. See our latest analysis for...
XTRA:CBK
XTRA:CBKBanks

Assessing Commerzbank (XTRA:CBK) Valuation After Recent Share Price Consolidation

Commerzbank stock overview after recent performance data Commerzbank (XTRA:CBK) is back in focus as investors assess its recent share performance, including a roughly flat move over the past month and a positive total return over the past 3 months. See our latest analysis for Commerzbank. While the share price has eased slightly in the last day, a 5.1% 7 day share price return and 5.7% 90 day share price return contrast with a year to date share price decline, alongside a very large 5 year...
XTRA:LHA
XTRA:LHAAirlines

A Look At Deutsche Lufthansa (XTRA:LHA) Valuation After Sector Weakness And Earnings Uncertainty

Deutsche Lufthansa (XTRA:LHA) is back in focus after a 54.51% share price drop on 23 February 2026, as sector weakness, margin pressure and elevated leverage met rising tension around the 6 March earnings announcement. See our latest analysis for Deutsche Lufthansa. The sharp 54.51% one day share price drop stands in contrast to Deutsche Lufthansa’s 30 day share price return of 4.27% and 1 year total shareholder return of 46.39%. This suggests that recent selling pressure has interrupted what...
XTRA:SY1
XTRA:SY1Chemicals

Assessing Symrise (XTRA:SY1) Valuation After Launching A €400 Million Share Buyback Program

Symrise (XTRA:SY1) has launched a €400 million share repurchase program. The company aims to buy back up to 10% of its share capital by October 2026, with redeemed shares reducing registered capital. See our latest analysis for Symrise. At a share price of €75.8, Symrise has seen positive short term momentum with a 30 day share price return of 4.44% and a 90 day return of 7.76%. However, the 1 year total shareholder return of 22.03% decline shows longer term holders have faced weaker outcomes...
XTRA:EUZ
XTRA:EUZMedical Equipment

A Look At Eckert & Ziegler’s (XTRA:EUZ) Valuation As Actinium‑225 Production Scales Up

Actinium-225 expansion reshapes Eckert & Ziegler’s role in radiopharmaceutical supply Eckert & Ziegler (XTRA:EUZ) has moved its Actinium-225 collaboration with the Czech Academy of Sciences into large scale production, making it one of the few suppliers able to deliver clinically relevant quantities globally. See our latest analysis for Eckert & Ziegler. The Actinium-225 expansion comes as Eckert & Ziegler’s €15.19 share price has a 1 day share price return of 2.5% and a 7 day share price...
XTRA:TMV
XTRA:TMVSoftware

Assessing TeamViewer (XTRA:TMV) Valuation After Mixed 2025 Earnings And Updated Analyst Ratings

TeamViewer (XTRA:TMV) is back in focus after its fourth quarter and full year 2025 earnings, with higher sales but lower full year net profit, alongside refreshed analyst coverage and ratings. See our latest analysis for TeamViewer. The mixed earnings picture and renewed analyst coverage come against a weak share price backdrop, with a 30 day share price return showing a 16.56% decline and a 1 year total shareholder return of 61.75% decline, suggesting sentiment has cooled even as revenue has...
XTRA:UN0
XTRA:UN0Renewable Energy

Uniper (XTRA:UN0) Valuation Check After New LNG Deal With Gujarat State Petroleum Corporation

Why the GSPC LNG deal matters for Uniper shares Uniper (XTRA:UN0) has signed a long term LNG supply agreement with Gujarat State Petroleum Corporation in India, linking the German utility more closely to one of the world’s fastest growing energy markets. See our latest analysis for Uniper. Despite the new LNG agreement with GSPC and a recent run of positive short term share price returns, including a 16.5% 90 day share price return to €35.7, Uniper’s 1 year total shareholder return of around...
XTRA:KBX
XTRA:KBXMachinery

A Look At Knorr-Bremse (XTRA:KBX) Valuation After Strong 2025 Results And Confident 2026 Guidance

What triggered the latest move in Knorr-Bremse stock? Knorr-Bremse (XTRA:KBX) shares reacted to the company’s full year 2025 earnings update, where management reported strong business performance under its BOOST program and issued 2026 guidance for €8.0 to €8.3 billion in revenue and an operating EBIT margin around 14%. See our latest analysis for Knorr-Bremse. Beyond the immediate reaction to the 2025 results and 2026 guidance, Knorr-Bremse’s recent move fits into a stronger trend, with a 30...